STOCK TITAN

Krystal Biotech to Present at Chardan’s 6th Annual Genetic Medicines Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Krystal Biotech, Inc. (NASDAQ: KRYS) will participate in Chardan’s 6th Annual Genetic Medicines Conference in New York on October 3-4, 2022. CEO Krish Krishnan will be featured in a fireside chat and hold investor meetings on October 4. A webcast of the presentation will be available starting at 9:00 AM ET on that date, accessible through the Company's website. Krystal Biotech is a pivotal-stage gene therapy firm focused on developing innovative treatments for serious and rare diseases.

Positive
  • None.
Negative
  • None.

PITTSBURGH, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, announced today that the Company will participate in the Chardan’s 6th Annual Genetic Medicines Conference in New York from October 3-4.

Krish Krishnan, Chairman and Chief Executive Officer, will participate in a fireside chat during the conference and host investor meetings on October 4.

A webcast of the presentation will be available here beginning at 9:00am ET on Tuesday, October 4 and will be posted on the Investor section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a pivotal-stage gene therapy company leveraging its proprietary, redosable gene therapy platform and in-house manufacturing capabilities to develop life-changing medicines for patients with serious diseases, including rare diseases in skin, lung, and other areas. For more information please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and Twitter.

CONTACT:

Investors and Media
Meg Dodge
Krystal Biotech
mdodge@krystalbio.com
Source: Krystal Biotech, Inc.


FAQ

What is the date of Krystal Biotech's participation in the Chardan conference?

Krystal Biotech will participate in the Chardan conference on October 3-4, 2022.

Who will represent Krystal Biotech at the conference?

CEO Krish Krishnan will participate in a fireside chat during the conference.

When will the webcast of Krystal Biotech's presentation be available?

The webcast will be available starting at 9:00 AM ET on October 4, 2022.

Where can I find more information about Krystal Biotech?

More information about Krystal Biotech can be found on their official website at krystalbio.com.

What is the focus of Krystal Biotech's gene therapy?

Krystal Biotech focuses on developing therapies for serious diseases, including rare skin and lung conditions.

Krystal Biotech, Inc.

NASDAQ:KRYS

KRYS Rankings

KRYS Latest News

KRYS Stock Data

4.74B
24.26M
12.3%
106.91%
12.53%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
PITTSBURGH